SCHEMBL19382541

SCHEMBL19382541

Nc1c(Br)cc(Nc2ccc(C(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RY4 P51582 7/20 0.69
▸ NTRK1 P04629 1/20 0.56
▸ NTRK2 Q16620 1/20 0.56
▸ GNG2 P59768 2/20 0.54
▸ GNB1 P62873 2/20 0.54
▸ P2RY12 Q9H244 7/20 0.53
▸ PLAUR Q03405 2/20 0.53
▸ P2RY2 P41231 6/20 0.53
▸ P2RY6 Q15077 4/20 0.53
▸ CDK2 P24941 2/20 0.53
▸ P2RY1 P47900 2/20 0.53
▸ ENTPD1 P49961 2/20 0.52
▸ PHLPP2 Q6ZVD8 1/20 0.52
▸ MET P08581 2/20 0.51
▸ HGF P14210 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11172913 0.88 P2RY4 (0.65) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL19359475 0.88 PLAUR (0.69) P2RY4GNG2GNB1P2RY12PLAUR
SCHEMBL11120841 0.86 P2RY4 (0.68) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL11337879 0.86 GNG2 (0.67) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL7630900 0.84 P2RY4 (0.68) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL19382542 0.83 P2RY4 (0.50) P2RY4NTRK1NTRK2GNG2GNB1
SCHEMBL13214019 0.83 P2RY4 (0.80) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL7949815 0.83 P2RY4 (0.69) P2RY4GNG2GNB1P2RY12P2RY2
SCHEMBL7944836 0.82 P2RY4 (0.56) P2RY4GNG2GNB1P2RY12PLAUR
SCHEMBL3016037 0.82 P2RY4 (0.78) P2RY4GNG2GNB1P2RY12P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161235-A1 PROCESS FOR PREPARING SUBSTITUTED 9,10-DIOXO-9,10-DIOXO-9,10-DIHYDROANTHRECENES AND 6H-ANTHRA(1,9-CD)ISOXAZOL-6-ONES PURDUE PHARMA L. P. (US) 2017-09-21 — — WO disclosed
Send feedback